Why isn't management addressing this?
LOL This has to be the only guy who will cheer when his own stock goes down every single day. You're quite the investor. LOL LOL LOL
Yeah, I admit it. I thought this quarter would do them in. Turns out it did not.
But, just like the tech bubble in the late 90's, RAD's run-up cannot be sustained with poor sales comps. At some point, you can no longer squeeze additional earnings out of decreasing sales.
Surprising, unaudited earnings comps can be a boon for share prices, but the underlying sales problems aren't going away. While smart investors will take the money and run, others will bask in their success and project future glory while getting the rug pulled out from under them.
Get ready for a massive realignment of prescription coverage.
This is really getting ridiculous!